The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran

Author(s):
Nasibe KarimiNasibe Karimi1, Ali BidmeshkipourAli Bidmeshkipour2, Keyghobad GhadiriKeyghobad Ghadiri3, Reza AlibakhshiReza Alibakhshi4,*
1Dept. of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Andorra
2Dept. of Biology, Faculty of Science, Razi University, Kermanshah, Iran
3Nosocomial Infectious Disease Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
4Dept. of Biochemistry, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
*Corresponding Author: Corresponding author: Reza Alibakhshi, Dept. of Biochemistry, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran, Tel: +988337213330 Email: [email protected]

Journal of Kermanshah University of Medical Sciences:Vol. 20, issue 4; e69663
Published online:Mar 19, 2017
Article type:Research Article
Received:Aug 21, 2016
Accepted:Jan 15, 2017
How to Cite:Karimi N, Bidmeshkipour A, Ghadiri K, Alibakhshi R. The molecular analysis of mutations in exons 4, 11 and 21 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis patients in Kermanshah, Iran. J Kermanshah Univ Med Sci. 2017;20(4):e69663. doi: https://doi.org/10.22110/jkums.v20i4.2466

Abstract

Introduction: Cystic fibrosis (CF) is a common genetic disorder in white populations with an autosomal recessive pattern, caused by mutations in the CFTR gene. The frequency of more than 1950 various mutations reported in the CFTR gene significantly varies in different populations. ∆F508 is a common mutation in exon 10, which is first addressed in the molecular analysis of the disease. Other exons are required to be investigated owing to failing to identify mutations in the patients. The present study was conducted to investigate mutations in exons 4, 11 and 21 of the CFTR gene using the sequencing method in CF patients in Kermanshah province, Iran.

Methods: The present descriptive study was conducted on all patients with CF presenting to the medical genetics center in Kermanshah in 2010-2011. After taking blood samples and extracting DNA using saturated NaCl solution, sequences of exons were amplified using PCR and sequenced for identifying mutations.

Results: The frequency of mutations was found to be respectively 0, 0 and 5.5% in exon 11, 21 and 4. The D110H mutation was found to be homozygous in one subject and heterozygous in another. Moreover, the 4029A>G polymorphism (12.9%) was found to be homozygous in two subjects and heterozygous in three others.

Conclusion: The D110H mutation is recommended to be included in the screening programs of the study population. The results obtained support the effects of ethnic and geographical factors on the distribution of CF mutations.

Fulltext

References

  • 1.
    The references of this article is available on PDF.

Copyright

© 2017, Journal of Kermanshah University of Medical Sciences. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

28
May
2014

Cystic fibrosis anddistribution and mutation analysis of CFTR gene in Iranian patients

Mohammad Reza Havasian,
Jafar Panahi,
Nejat Mahdieh

Havasian MR, Panahi J, Mahdieh N. Cystic fibrosis anddistribution and mutation analysis of CFTR gene in Iranian patients. koomesh. 2014;15(4):e152879. doi:

17
Jan
2013

Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran

Shirin Farjadian,
Mozhgan Moghtaderi,
Sara Kashef,
Soheila Alyasin,
Khadijehsadat Najib,
Forough Saki

Farjadian S, Moghtaderi M, Kashef S, Alyasin S, Najib K, et al. Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran. Inn J Pediatr. 2013;23(2):. doi:

23
Dec
2015

Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency

Ahmad Khodadad,
Elaheh Elahi,
Setareh Sadat Bani Hassani,
Pejman Rouhani,
Bamdad Sadeghi,
Nima Rezaei

Khodadad A, Elahi E, Bani Hassani SS, Rouhani P, Sadeghi B, et al. Frequency of Genotype With ΔF508 Mutation in CFTR Gene Among Iranian Cystic Fibrosis Patients With Pancreatic Insufficiency. Inn J Pediatr. 2015;25(6):e3419. doi: https://doi.org/10.5812/ijp.3419

21
May
2009

Analysis of CFTR gene mutations in Iranian non - obstructive azoospermic patients

Reza Mirfakhraie,
SM Kalantar,
n Salsabili,
Maryam Montazeri,
h Fazli,
Massoud Houshmand
,et al.

Mirfakhraie R, Kalantar S, Salsabili N, Montazeri M, Fazli H, et al. Analysis of CFTR gene mutations in Iranian non - obstructive azoospermic patients. Zahedan J Res Med Sci. 2008;10(4):e94501. doi:

8
Aug
2021
Zahedan J Res Med Sci

Mutational Analysis of Mucopolysaccharidosis in Iranian Patients

Seyed Hoseinali Saberi,
Shahla Farshidi,
Behnam Kamalidehghan,
Roshanak Jazayeri,
Massoud Houshmand

Saberi SH, Farshidi S, Kamalidehghan B, Jazayeri R, Houshmand M. Mutational Analysis of Mucopolysaccharidosis in Iranian Patients. Zahedan J Res Med Sci. 2021;23(3):e104794. doi: https://doi.org/10.5812/zjrms.104794

Download PDF432.45 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles